Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Prion diseases are a group of rare transmissible disorders characterized by progressive debilitating neurological manifestations due to spongiform changes with an invariably fatal course. The disorders all involve accumulation of an abnormal prion protein in the central nervous system with no specific immunological response. Sporadic Creutzfeldt-Jakob disease (CJD) is the most frequent form accounting for about 85% of prion disease cases. The other forms of prion disease are genetic (5-15%) and include inherited CJD, fatal familial insomnia (FFI), and Familial Alzheimer-like prion disease. Acquired forms (< 5%) include iatrogenic CJD and variant CJD (vCDJ).
Biomarker and diagnostic research for human prion disease has been reported in the published literature.
Estimated prevalence: 1-9 in 1,000,000 (Rare).
2 clinical trials registered, 1 recruiting. Interventions under study include drug therapy. Pipeline includes 2 PHASE1. Research is sponsored by a mix of industry and academic institutions.
73 publications have been identified in PubMed for human prion disease. Research spans Basic Science / Preclinical (40%), Epidemiology / Natural History (22%), and Diagnostic / Biomarker (11%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 29 | 40% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 8:50 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression |
16 |
22% |
Testing and diagnosis research | 8 | 11% |
Research summaries | 6 | 8% |
Patient case studies | 5 | 7% |
New treatment approaches | 5 | 7% |
Clinical study results | 3 | 4% |
Other research | 1 | 1% |
Suzuki A (2026). [PMID: 41901786](https://pubmed.ncbi.nlm.nih.gov/41901786/). *Pathogens*. [Diagnostic / Biomarker]
Skáčik P (2026). [PMID: 41973065](https://pubmed.ncbi.nlm.nih.gov/41973065/). *Cent Eur J Public Health*. [Case Report / Case Series]
Nicholson EM (2026). [PMID: 41857788](https://pubmed.ncbi.nlm.nih.gov/41857788/). *BMC Res Notes*. [Diagnostic / Biomarker]
Appleby BS (2026). [PMID: 41528501](https://pubmed.ncbi.nlm.nih.gov/41528501/). *Acta neuropathologica*. [Basic Science / Preclinical]
Zitser J (2026). [PMID: 40152909](https://pubmed.ncbi.nlm.nih.gov/40152909/). *Brain : a journal of neurology*. [Clinical Trial Publication]
Wright EA (2026). [PMID: 41976043](https://pubmed.ncbi.nlm.nih.gov/41976043/). *Animals (Basel)*. [Basic Science / Preclinical]
Nikolić L (2026). [PMID: 42053126](https://pubmed.ncbi.nlm.nih.gov/42053126/). *Expert Opin Drug Discov*. [Review / Meta-Analysis]
Abdul H (2026). [PMID: 41238228](https://pubmed.ncbi.nlm.nih.gov/41238228/). *Annual review of animal biosciences*. [Clinical Trial Publication]
Marzola GP (2026). [PMID: 42076770](https://pubmed.ncbi.nlm.nih.gov/42076770/). *Vet Sci*. [Review / Meta-Analysis]
Silva CJ (2026). [PMID: 41677576](https://pubmed.ncbi.nlm.nih.gov/41677576/). *Journal of the American Society for Mass Spectrometry*. [Basic Science / Preclinical]
AI-curated news mentioning human prion disease
Updated Aug 19, 2026
A recent study estimates the penetrance of PRNP mutations in Chinese patients with prion disease, utilizing genome databases for analysis. This research contributes to understanding genetic factors in prion disease, which may inform future therapeutic strategies.
Recent research highlights multi-target strategies in drug discovery for prion diseases, aiming to improve therapeutic outcomes. This update provides insights into current methodologies and potential avenues for future research.